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Abstract 
A male Afro-descendant patient, 57 years old, complaining of polyarticular involvement and 
weight loss for 18 months, with a load of 13.5 pack years of smoking. On physical 
examination there was pain on palpation of the right knee and right leg, with signs of 
inflammation on the knee. We also observed digital clubbing in all fingers. Antinuclear 
antibodies (ANA) and anti-Sm antibodies were positive. X-rays of the legs and arm showed 
cortical thickening of long bones. The computed tomography demonstrated a large mass 
located in the middle lobe of the right lung. The anatomopathological study revealed a 
bronchial adenocarcinoma. The history of polyarticular involvement associated with positive 
anti-Sm and ANA antibodies could lead to an erroneous diagnosis of systemic lupus 
erythematosus. Considering the bad consequences of delayed diagnosis in this patient, the 
medical team should be alerted for suspecting and look for a lung cancer under these 
circumstances. 
 
Introduction 
The term ‘pulmonary hypertrophic osteoarthropathy’ (PHO) was proposed by Marie 
in 1890, while one year before Bamberger had described two patients with 
hypertrophic osteoarthropathy related to bronchiectasis [1]. PHO, also known as Pierre 
Marie-Bamberger Syndrome, is characterized by proliferative periostitis of long bones, 
digital clubbing, polyarticular or oligoarticular manifestations [2]. It is commonly 
associated with intrathoracic malignancies, and related to primary lung cancer in 80%  
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of patients. According to the literature 0.2% to 17% of patients with lung cancer 
develop PHO [1]. The literature has described the syndrome in the absence of 
antinuclear antibodies. 
Solans-Laqué et al. [3], nevertheless, have demonstrated antinuclear autoantibodies 
(ANA) in 27.7% of patients with malignancies when compared with only 6.4% in 
healthy subjects. Shoenfeld and colleagues [4] found anti-RNP and anti-Sm antibodies 
in 16 (21.7%) and 14 lymphoma patients (20%), respectively, significantly more than 
in the controls (p < 0.05) in both antibodies. These findings were valid for those with 
Hodgkin and non-Hodgkin lymphoma. 
We report herein a case of PHO with polyarticular involvement and detectable 
antinuclear and anti-Sm antibodies. 
Case Report 
A male, Afro-descendant 57-year-old complained of pain of strong intensity in the right ankle, right 
shoulder joints, and both knees with local edema eighteen months ago. The patient did not notice 
triggers of pain but had improvement with anti-inflammatory medicines. He did not mention alopecia, 
malar rash, photosensitivity, dark urine, decreased urine volume, seizures and behavior changes. 
He observed weight loss of 11 kg in recent months, sporadic dry cough and an episode of coughing 
up bloody sputum a month ago. He is a former smoker and had quit smoking for 13 years, with a load 
of 13.5 pack years of smoking. 
Laboratory tests requested on another rheumatologic clinic revealed: red blood cell counts 
4,880,000/ml, hemoglobin 10.2 g/dl, hematocrit 33.9%, with negative Coombs, platelets 520,000/ml, 
total leukocyte count 8,000/ml, erythrocyte sedimentation rate 51 mm/first hour, urea 32 mg/dl, 
creatinine 0.8 mg/dl, AST 33 U/l, ALT 20 U/l, gamma-GT 107 U/l, C-reactive protein 143.0 mg/l, 
Waaler-Rose 256 IU/ml, positive ANA 1/5,120 (speckled pattern), anti-DNA negative, anti-Sm 156 
(repeated and confirmed in independent samples of serum), IgG and IgM serology for Epstein-Barr 
was negative; C3 171.0, C4 32.60, rheumatoid factor 429 IU/ml, normal urine exam, 24-hour 
proteinuria 216 mg. 
On physical examination the patient was thin, afebrile, with digital clubbing in all fingers (fig. 1). 
Examination of skin showed no malar rash or alopecia. Oropharyngeal examination did not present 
ulcers. Osteoarticular apparatus: there was pain on palpation of the right knee and right leg, with 
signs of inflammation on the right knee. Respiratory system: reduced breath sounds in the lower two-
thirds of the right hemithorax without stertors and no pleural rub. Cardiovascular system: blood 
pressure 125 × 75 mm Hg, HR 84 bpm, normal and rhythmic beats in two phases, with no murmurs 
and no pericardial rub. Neurological exam: no abnormal findings. 
Among imaging tests performed, chest X-rays showed homogeneous opacity of partially defined 
contours, located in the anterior portions of the right lung basis. Computed tomography demonstrated 
a large mass (10.0 × 10.0 cm in greatest diameter) with heterogeneous density at the expense of 
central necrosis, located in the middle lobe of the right lung (fig. 2). X-rays of the legs and arm 
showed cortical thickening of long bones (fig. 3). 
Bronchoscopy showed in the right bronchial tree a vegetative tumor with friable coating almost 
completely obstructing the lumen of the bronchus. The anatomopathological study revealed a 
bronchial adenocarcinoma.  
Case Rep Oncol 2012;5:308–312 
DOI: 10.1159/000339571 
Published online: 
June 12, 2012 
© 2012 S. Karger AG, Basel 
ISSN 1662–6575 
www.karger.com/cro 
 
 
 
310 
Discussion 
PHO has been described in the literature with negative ANA, but the presence of 
these antibodies has been related to cancer [3]. Madrid et al. [5] found that presence of 
ANA was consistent in most lung cancer patients in their casuistic in a dilution of up to 
1:500. 
The significance of antinuclear antibodies in malignancies is not well understood 
according to Zuber [6]. The antigens may be specific to each type of tumor and the 
production of antibodies would be an attempt to neutralize them. Cancer patients may 
develop many kinds of autoantibodies resulting from tissue damage and necrosis, 
allowing the generation of proteins that are usually not recognized by the immune 
system. 
The occurrence of articular involvement with positive ANA and anti-Sm is the 
unusual presentation in this case report. 
Anti-Sm antibodies (ELISA) have been pointed out as having a high specificity for 
lupus diagnosis (95–98%) [6]. False positives have been reported in cases of Hodgkin 
and non-Hodgkin lymphoma [4], rheumatoid arthritis [7], infection with Epstein-Barr 
virus [8], Malaysian ethnicity [9], relatives of schizophrenics and schizophrenics [10]. 
Considering the size of the mass (10.0 × 10.0 cm in greatest diameter), it is 
reasonable to assume that lung cancer was already present when the patient developed 
severe pain involving the right ankle, right shoulder and both knees eighteen months 
before hospitalization. This temporal relationship between the malignancy and the 
appearance of osteoarticular signs and symptoms according to McLean [11] reinforces 
the diagnosis of a paraneoplastic syndrome. 
The history of polyarticular involvement associated with positive anti-Sm and ANA 
could lead to an erroneous diagnosis of systemic lupus erythematosus, since these 
antibodies are highly specific for the diagnosis of this disease. Considering the bad 
consequences of delayed diagnosis in a patient with bronchial adenocarcinoma, the 
medical team should be alerted for suspecting and look for a lung cancer under these 
circumstances. 
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Fig. 1. Digital clubbing in hands and feet. 
 
 
 
Fig. 2. Chest X-rays in AP and chest computed tomography. 
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Fig. 3. Periostitis involving the right humerus and tibias bilaterally. 
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